Algernon Pharmaceuticals Begins Manufacturing of Repirinast and Launches New Chronic Kidney Disease Research Program
February 23, 2022 07:00 ET
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGWO) (OTCQB: AGNPF) a clinical stage pharmaceutical...
FibroGen to Report Fourth Quarter and Full Year 2021 Financial Results
February 14, 2022 07:00 ET
|
FibroGen, Inc.
SAN FRANCISCO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its fourth quarter and full year 2021 financial results on Monday, February 28 after the market close....
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Reata Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – RETA
February 09, 2022 17:15 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 09, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between...
FibroGen to Present at SVB Leerink 11th Annual Global Healthcare Conference
February 04, 2022 07:00 ET
|
FibroGen, Inc.
SAN FRANCISCO, Feb. 04, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the SVB Leerink...
KidneyDiet App Brings Expert Nutritional Guidance to Those Suffering from Chronic Kidney Disease
January 25, 2022 08:00 ET
|
Kismetly, Inc.
BOULDER, Colo., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Kismetly Inc., maker of the number one downloaded kidney-health nutrition app to help people manage chronic kidney disease through informed...
Clover Health Launches New Clinical Program Targeting Chronic Kidney Disease in Partnership with Cricket Health
December 09, 2021 09:00 ET
|
Clover Health Investments, Corp.
The Clover Assistant synthesizes health data and surfaces personalized clinical recommendations to physicians to drive earlier disease detection and interventionSpecialty kidney services now...
Hematuria Treatment Market Size ($1,103.61Mn by 2028) Led by Urinary Tract Infections (17.31% Market Share in 2020) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 29, 2021 13:45 ET
|
The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Hematuria Treatment Market: Key InsightsAccording to our new research study on Hematuria Treatment Market Size and Forecast to 2028 - COVID-19 Impact and...
Global Renal Care Management Market Research Report 2021: Value-based Renal Care to Provide a Strong Platform for Payer-driven Innovations and Major Industry Disruptions
September 29, 2021 07:13 ET
|
Research and Markets
Dublin, Sept. 29, 2021 (GLOBE NEWSWIRE) -- The "Global Renal Care Management Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The global prevalence of CKD is...
ARDX FINAL DEADLINE TUESDAY: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Ardelyx, Inc. Investors with Losses to Secure Counsel Before Important September 28 Deadline in Securities Class Action – ARDX
September 26, 2021 15:15 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 26, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ardelyx, Inc. (NASDAQ: ARDX) between August 6, 2020 and...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Ardelyx, Inc. Investors with Losses to Secure Counsel Before Important September 28 Deadline in Securities Class Action – ARDX
September 17, 2021 19:15 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 17, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ardelyx, Inc. (NASDAQ: ARDX) between August 6, 2020 and...